Whats happening: The digital health company unveiled a diagnostics-driven microdosed GLP-1 program to preempt and reverse chronic disease completing its evolution from diet app to full-stack preventative health platform
Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study
Eating three smaller meals plus two snacks throughout the day prevents the deep energy valleys that come with long fasting gaps
Table of Contents How Long Retatrutide Remains Stable After Reconstitution Correct Storage Conditions for Reconstituted Retatrutide Signs That a Reconstituted Solution Has Degraded Safe Handling and Disposal of Reconstituted Injectable Peptides What to Do If You Have Concerns About a Prepared Dose Current Regulatory Status of Retatrutide in the UK Scientific References Frequently Asked Questions How Long Retatrutide Remains Stable After Reconstitution No MHRA-approved or manufacturer-validated stability data exist for retatrutide
As a GLP-1, GIP, and glucagon receptor agonist being evaluated for obesity and type 2 diabetes, retatrutide shares some skin-related adverse effects with other subcutaneous incretin therapies, whilst its full dermatological profile remains under investigation
In a separate study , published in JAMA in August 2025, the same researchers found that, across ages, GLP-1s were associated with lower risk of some obesity-related cancers, such as endometrial, ovarian, and meningioma cancers, but with an increased risk of kidney cancer, and nonsignificant changes for several other cancers
.webp)
